CSPC Innovation Pharmaceutical (300765.SZ) completed a repurchase of 12.002 million shares at a cost of 321 million yuan.
New Noble (300765.SZ) announcement, as of September 20, 2024, the company has completed the share repurchase through special certificates...
CSPC Innovation Pharmaceutical (300765.SZ) announced that as of September 20, 2024, the company repurchased 12.002 million shares of the company through a special securities account for share repurchase using centralized bidding trading, accounting for 0.85% of the company's current total share capital. The highest transaction price was 34.99 yuan per share, the lowest transaction price was 18.68 yuan per share, and the total amount paid was 321 million yuan (excluding transaction costs). The buyback period has expired, and the buyback plan has been completed.
Related Articles

NEWAY GROUP (00055): Zhang Yushan appointed as the new company secretary.

GLORIOUS PPT H(00845): Property units selling and delivering total construction area exceeding 70,000 square meters in 2025.

SINOMAB BIO-B (03681): The first patient in China with atopic dermatitis completes Phase 2 clinical trial of SM17 treatment.
NEWAY GROUP (00055): Zhang Yushan appointed as the new company secretary.

GLORIOUS PPT H(00845): Property units selling and delivering total construction area exceeding 70,000 square meters in 2025.

SINOMAB BIO-B (03681): The first patient in China with atopic dermatitis completes Phase 2 clinical trial of SM17 treatment.






